What is bacteriostatic water?
Bacteriostatic water is a USP-monographed parenteral diluent consisting of sterile water for injection with 0.9% benzyl alcohol added as an antimicrobial preservative. The preservative supports multi-dose draw across the multi-week post-reconstitution stability window of typical research peptides, distinguishing it from preservative-free sterile water for injection (single-use only).
What the research literature says
Bacteriostatic water for injection (BWFI) is the standard reconstitution diluent for research peptides because most research protocols draw successive doses from a single reconstituted vial across days or weeks. The 0.9% benzyl alcohol preservative provides antimicrobial protection across the labelled 28-day in-use stability window after first puncture of the rubber stopper, preventing microbial contamination from compromising the experimental compound between draws (assuming aseptic technique on each puncture).
The USP <1231> general chapter on Water for Pharmaceutical Purposes defines the parenteral-grade water hierarchy: Water for Injection (WFI) is the base specification, BWFI adds the benzyl alcohol preservative, and Sterile Water for Injection (SWFI) is WFI packaged in single-use sterile containers without preservative. The USP BWFI monograph covers composition, sterility, endotoxin, and in-use stability specifications.
Benzyl alcohol is bacteriostatic (inhibits bacterial growth at the in-vial concentration) rather than bactericidal (actively kills organisms) — the distinction explains why aseptic technique remains required at each puncture even with the preservative present. The preservative reduces microbial-contamination risk during the in-use window but does not eliminate the need for sterile-handling practice.
Why this matters in research context
The choice of bacteriostatic water over plain sterile water shapes the post-reconstitution handling workflow. With BWFI, a single reconstituted vial supports multi-week multi-dose draw across most research protocols. With SWFI, each reconstituted vial is single-use — the full volume must be drawn and used immediately or discarded. The bacteriostatic-water workflow is the operational default for almost all research-peptide protocols.
Related compounds
- Bacteriostatic water (glossary entry) — composition, history, alternatives
- Reconstitution guide — operational protocols using BWFI
Related research questions
- How do bacteriostatic water and sterile water differ?
- How do you reconstitute a lyophilized peptide?
- How do you store lyophilized peptides?
References
- United States Pharmacopeia <1231> Water for Pharmaceutical Purposes. General chapter defining Water for Injection, Bacteriostatic Water for Injection, and Sterile Water for Injection specifications. United States Pharmacopeia.
- USP Bacteriostatic Water for Injection monograph. Composition (WFI plus 0.9% benzyl alcohol), labelled storage, and in-use stability windows. United States Pharmacopeia.
Research-questions pages describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. Every compound in the Ronin catalog is sold strictly for laboratory and research use only.